| 询价 | |
| M00593 | |
|
|
|
|
|
|
|
|
|
| 咨询产品问题 | |
| Product Description | Recombinant CHO-K1 cells stably overexpress human C-type lectin domain family 4 member C (BDCA2) and Fc epsilon receptor Ig (FcER1G) on the surface. The surface expression of BDCA2 is validated by FACS analysis. |
| Culture Properties | Adherent. |
| Stability | Stable through more than 16 passages without significant changes in assay performance or expression profile. |
| Size | Two vials of frozen cells (>1×106 per vial in 1 mL). |
| Storage | Store cells in liquid nitrogen immediately upon receipt. Thaw and recover cells within one year from the date received. |
| Culture Medium | Ham’s F-12K (Kaighn’s), 10% FBS, 8 μg/ml Puromycin (Cat. No. A11138-03, Life Technologies) |
| Complete Growth Medium | Ham’s F-12K (Kaighn’s) (Cat. No. 21127-022, Life Technologies), 10% FBS (Cat. No. 10099-141, Life Technologies) |
| Freeze Medium-DATA | 95% complete growth medium, 5% (V/V) DMSO (Cat. No. D2650, Sigma) |
Figure 1. FACS analysis of human BDCA2 expression in CHO-K1/BDCA2/FcER1G cells. The CHO-K1/BDCA2/FcER1G cells (blue) and the negative control CHO-K1 cells (red) were probed using PE conjugated Anti-BDCA2 (Cat. No. 130-090-511, Miltenyi). »
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
